CX717 is an ampakine compound created by Christopher Marrs and Gary Rogers in 1996 at Cortex Pharmaceuticals. It affects the neurotransmitter glutamate, with trials showing the drug improves cognitive functioning and memory.
Read more about CX717: Approval Process, Use For Reversal of Respiratory Depression, Related AMPAkines